1. Li J, Tripathi RC, Tripathi BJ (2008) Drug-induced ocular disorders. Drug Saf 31:127–141
2. Somps CJ, Greene N, Render JA, Aleo MD, Fortner JH, Dykens JA, Phillips G (2009) A current practice for predicting ocular toxicity of systemically delivered drugs. Cutan Ocul Toxicol 28:1–18
3. ZOCOR, NDA no. 019766, product label approved 6/11/2008. United States Food and Drug Administration. Accessed 12 Jan 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019766s076lbl.pdf
4. Greaves P, Goonetilleke R, Nunn G, Topham J, Orton T (1993) Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. Cancer Res 53:3919–3924
5. MEVACOR, NDA no. 019643, product label approved 3/9/2009. United States Food and Drug Administration, Accessed 12 Jan 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019643s080lbl.pdf